Homocysteine-lowering action is another potential cardiovascular protective factor of aged garlic extract

Journal of Nutrition

Volumn 136, Issue 3, 2006, Pages

  Yeh, Yu Yan ^a   Yeh, Shaw Mei ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Folate deficiency; Garlic; Hyperhomocysteinemia; Total homocysteine

Indexed keywords

CYSTEINE; CYSTEINYLGLYCINE; FOLIC ACID; GARLIC EXTRACT; GLUTATHIONE; HOMOCYSTEINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SUCCINYLSULFATHIAZOLE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; FOLIC ACID DEFICIENCY; HEART PROTECTION; HYPERHOMOCYSTEINEMIA; MALE; NONHUMAN; RAT;

ALLIUM SATIVUM; ANIMALIA;

EID: 33644836812     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.3.745s     Document Type: Conference Paper

References (38)

1. Anderson RN, Smith BL. Deaths: leading causes for 2002. Natl Vital Stat Rep. 2005;53:1-89.
2. Simons LA, Sullivan DR. Lipid-modifying drugs. Med J Aust. 2005;182:286-9.
3. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005;85:571-633.
4. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-52.
5. Berg CM, Lissner L, Aires N, Lappas G, Toren K, Wilhelmsen L, Rosengren A, Thelle DS. Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results for INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil. 2005;12:115-25.
6. Stampfer MJ, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med. 1995;332:328-9.
7. Clarke R, Daly L, Robinson K, Naughten E, Cahalane E, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-55.
8. Chamberlain K. Homocysteine and cardiovascular disease: A review of current recommendations for screening and treatment. J Am Acad Nurse Pract. 2005;17:90-5.
9. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 2002;105:22-6.
10. Chai AU, Abrams J. Homocysteine: a new cardiac factor? Clin Cardiol. 2001;24:80-4.
11. Seshadri N, Robinson K. Homocysteine and coronary risk. Curr Cardiol Rep. 1999;1:91-8.
12. Boers GH. Mild hyperhomocysteinemia is an independent risk of arterial vascular disease. Semin Thromb Hemost. 2000;26:291-5.
13. Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr, editors. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function, New York: Marcel Dekker; 1992. p. 183-236.
14. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullman O, Tishler PV, Hennekens CH. A prospective study of plasma homocysteine and risk of myocardial infarction in U.S. physicians. JAMA. 1992;268:877-81.
15. Massy ZA, Chadefaux-Vekemans B, Chevalier A, Bader CA, Drueke TB, Legendre C, Lacour B, Kaamon P, Kreis H. Hyperhomocysteinemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant. 1994;9:1103-8.
16. Tsai JC, Perrella MA, Hsieh CM, Harrber E, Schlegel R, Lee ME. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA. 1994;91:6369-73.
17. Das UN. Folic acid says NO to vascular disease. Nutrition. 2003;19:686-92.
18. Tyagi Sc. Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix. Clin Exp Hypertens. 1999;21:181-98.
19. Moat SJ, Lang D, McDowell IFW, Clarke ZL, Madhavan AK, Lewis MJ, Goodfellow J. Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem. 2004;15:64-79.
20. Brattstrom L, Lindgren A, Israelsson B, Anderson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med. 1994;236:633-41.
21. Selhub J, Jacques PF, Bostom AG, O'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg, IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286-91.
22. Kado DM, Karlamangla AS, Huang MH, Toren A, Rowe JW, Selhub J, Seeman TE. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning aduls: MacArthur Studies of Successful Aging. Am J Med. 2005;118:161-7.
23. Aguilar B, Rojas JC, Collados MT. Metabolism of homocysteine and its relationship with cardiovascular disease. J Thromb Thrombolysis. 2004;18:75-87.
24. Takenaka T, Shimomura T, Nakayasu H, Urakami K, Takahashi K. Effect of folic acid for treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Rinsho Shinkeigaku-Clin Neurol. 1993;33:1140-5.
25. Yeh Y-Y, Lim H-S, Yeh S-M, Picciano MF. Garlic extract attenuates hyperhomocysteinemia caused by folic acid deficiency in the rat. Nutr Res. 2005;25:93-102.
26. Steiner M, Khan AH, Holbert D, Lin RI. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr. 1996;64:866-70.
27. Yeh Y-Y, Liu L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: Human and animal studies. J Nutr. 2001;131:989S-93S.
28. Ide N, Lau BHS, Ryn K, Matsuura H, Itakura Y. Antioxidant effects of fructosyl arginine, a Maillard reaction product in aged garlic extract. J Nutr Biochem. 1999;10:372-6.
29. Clifford AJ, Bills ND, Peerson JM, Muller HG, Burk GE, Rich KD. A depletion-repletion folate bioassay based on growth and tissue folate concentrations of rats. J Nutr. 1993;123:926-32.
30. Miller JW, Nadeau MR, Smith I, Smith O, Selhub J. Folate- deficiencyinduced homocysteinemia in rats: disruption of S-adenosylmethionine's coordinate regulation of homocysteine metabolism. Biochem J. 1994;298:415-9.
31. Tamura T. Microbiological assay of folate. In: Picciano MF, Stokstad ELR, Grepory JF, editors. Folic acid metabolism in health and disease, New York: Wiley-Liss, 1990. p. 121-37.
32. Wilson SD, Horne DW. Use of glycerol-cryoprotected Lactobacillus casei for microbiological assay of folic acid. Clin Chem. 1982;28:1198-200.
33. Wilson SD, Horne DW. High-performance liquid chromatographic determination of the distribution of naturally occurring folic acid derivatives in rat liver. Anal Biochem. 1984;142:529-35.
34. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detector. J Chromatogr. 1987;422:43-52.
35. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem. 1991;29:549-54.
36. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217-46.
37. Green R, Jacobsen DW. Clinical implications of hyperhomocysteinemia. In: Baily LB, editor. Folate in health and disease, New York: Marcel Dekker, 1995. p. 75-123.
38. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr. 1994;124:1934-41.